Well Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 72.7669 million yuan, a year-on-year decrease of 7.77%

Well Pharmaceutical released its semi-annual report for 2025, with operating revenue of 674 million yuan, a year-on-year decrease of 2.10%; net profit attributable to the parent company was 72.7669 million yuan, a year-on-year decrease of 7.77%. The net profit after deducting non-recurring gains and losses was 72.2489 million yuan, a year-on-year increase of 4.12%. Basic earnings per share were 0.54 yuan